Aveo Capital Partners, LLC Abb Vie Inc. Transaction History

Aveo Capital Partners, LLC

$910 Million
Q3 2024

A detailed history of Aveo Capital Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Aveo Capital Partners, LLC holds 2,721 shares of ABBV stock, worth $489,780. This represents 0.06% of its overall portfolio holdings.

Number of Shares

2,721

Previous 3,247 16.2%

Holding current value

$489,780

Previous $556,000 3.42%

% of portfolio

0.06%

Previous 0.07%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $86,179 - $104,847	-526 Reduced 16.2%	2,721 $537,000
Q2 2024 Aug 02, 2024	SELL	$154.79 - $180.76 $153,706 - $179,494	-993 Reduced 23.42%	3,247 $556,000
Q1 2024 May 06, 2024	SELL	$159.82 - $182.1 $9,109 - $10,379	-57 Reduced 1.33%	4,240 $772,000
Q4 2023 Feb 06, 2024	BUY	$137.6 - $154.97 $28,896 - $32,543	210 Added 5.14%	4,297 $665,000
Q3 2023 Nov 06, 2023	BUY	$133.59 - $154.65 $20,038 - $23,197	150 Added 3.81%	4,087 $609,000
Q2 2023 Aug 08, 2023	SELL	$132.51 - $164.9 $9,805 - $12,202	-74 Reduced 1.84%	3,937 $530,000
Q1 2023 May 03, 2023	BUY	$144.61 - $166.54 $247,572 - $285,116	1,712 Added 74.47%	4,011 $639,000
Q4 2022 Feb 03, 2023	BUY	$138.31 - $165.87 $13,277 - $15,923	96 Added 4.36%	2,299 $371,000
Q3 2022 Nov 09, 2022	SELL	$134.21 - $153.93 $32,613 - $37,404	-243 Reduced 9.93%	2,203 $296,000
Q2 2022 Aug 05, 2022	SELL	$137.62 - $174.96 $6,468 - $8,223	-47 Reduced 1.89%	2,446 $375,000
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $177,513 - $220,243	-1,345 Reduced 35.04%	2,493 $404,000
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $35,022 - $44,313	326 Added 9.28%	3,838 $520,000
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $8,086 - $9,179	76 Added 2.21%	3,512 $379,000
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $1,998 - $2,226	19 Added 0.56%	3,436 $387,000
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $349,559 - $384,822	3,417 New	3,417 $370,000
Q4 2019 Feb 06, 2020	SELL	$72.13 - $90.25 $186,311 - $233,115	-2,583 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$62.98 - $75.72 $162,677 - $195,584	2,583 New	2,583 $214,000
Q1 2019 May 07, 2019	SELL	$77.14 - $90.79 $190,150 - $223,797	-2,465 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$77.85 - $96.01 $191,900 - $236,664	2,465 New	2,465 $227,000
Q3 2018 Nov 09, 2018	SELL	$88.91 - $98.84 $224,319 - $249,373	-2,523 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $16,070 - $19,015	179 Added 7.64%	2,523 $234,000
Q1 2018 May 11, 2018	SELL	$92.01 - $123.21 $21,346 - $28,584	-232 Reduced 9.01%	2,344 $222,000
Q4 2017 Feb 05, 2018	SELL	$89.56 - $98.21 $13,254 - $14,535	-148 Reduced 5.43%	2,576 $249,000
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $190,271 - $243,035	2,724	2,724 $242,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aveo Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aveo Capital Partners, LLC with notifications on news.

Account

Aveo Capital Partners, LLC Abb Vie Inc. Transaction History